Vahanna Tech Edge Acquisition I Corp. (NASDAQ:VHNA) has closed its combination with insuretech firm Roadzen and its shares and warrants will begin trading on the Nasdaq tomorrow, September 21, under the symbols “RDZN” and “RDZNW”.
The SPAC secured shareholder approval for the deal about a month ago in an August 25 vote and it has not yet released final redemption figures. However, it noted at the time that it had also deposited $225,000 in its trust to fund a one-month extension to its deadline, which represented a whopping $5.38 per public share.
That would mean the SPAC has about 41,821 public shares remaining, and its stock has picked up some notable momentum hitting a high of $17 today.
Last month, Vahanna signed a forward purchase agreement with Meteora Capital Partners and affiliates covering up to 5,000,000 shares or 9.9% of Vahanna’s total public float at close, which is also to factor in.
The parties initially announced the $965 million deal in February. New Delhi-based Roadzen provides B2B AI solutions to the auto insurance market primarily to automakers and fleet operators.
ADVISORS
- Winston & Strawn LLP is acting as legal counsel to Roadzen.
- Mizuho Securities USA LLC is acting as financial advisors to Vahanna.
- Pi Capital LLC is acting as financial advisors to Vahanna.
- Gibson, Dunn & Crutcher LLP is acting as legal counsel to Vahanna.
- DMD Advocates is acting as legal counsel to Vahanna.
- Sidley Austin LLP is acting as legal counsel to Mizuho
- Sheumack GMA is acting as Fairness Opinion advisor to Vahanna’s board of directors.
At the SPAC of Dawn The rebound of the growth companies that made up the SPAC class of 2021 has been one of the bigger stories of second half of 2024, but not all of the de-SPACs are feeling the love equally. Instead, in many new sectors that hit the public markets together as a...
DT Cloud (NASDAQ:DYCQ) has entered into a definitive agreement to combine with Maius Pharmaceutical at an equity value of $250 million. Shanghai-based Maius is a drug developer and researcher focused on small-molecule chemical treatments for different forms of cancer. The combined company is expected to trade on the Nasdaq once the deal is completed in...
Charlton Aria Acquisition Corporation announced the pricing of its $75 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “CHARU”, Thursday, October 24, 2024. The new SPAC plans to focus on industries that complement the management team’s and board of director’s background and network. The sponsor team for...
At the SPAC of Dawn As the market goes through a cooling period this week, new readouts for jobless claims and new home sales are set to hit later today. Jobless claims are of course something of a proxy indicator for SPACs as to when the Fed might continue to its rate-cutting process, while home...
Bold Eagle Acquisition Corp. announced the pricing of its $250 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “BEAGU”, Thursday, October 24, 2024. The new SPAC plans to search for a combination target valued at $3 billion or more that would benefit from the relationships and experience...